Can the Glittre ADL test differentiate the functional capacity of COPD patients from that of healthy subjects?

Fuente: Redalyc
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Krislainy S. Corrêa
Format: Artículo científico
Sprache:en
Veröffentlicht: Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia 2011
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1876467357837164544
author Krislainy S. Corrêa
author_facet Krislainy S. Corrêa
contents Can the Glittre ADL test differentiate the functional capacity of COPD patients from that of healthy subjects? Krislainy S. Corrêa Manuela Karloh Letícia Q. Martins Karoliny dos Santos Anamaria F. Mayer Salud Evaluation rehabilitation pulmonary disease chronic obstructive activities of daily living BACKGROUND: The Glittre ADL (TGlittre) test is a specifically designed to assess functional limitation in chronic obstructive pulmonary disease (COPD) patients. However, it is not known if it can differentiate the performance of these patients from healthy subjects. OBJECTIVES: To investigate whether the Glittre ADL test is able to differentiate the functional capacity of COPD patients from that of healthy subjects and to compare the cardiorespiratory response between Glittre ADL and the six-minute walk test (6MWT). METHODS: The study included 10 patients with COPD (GOLD 2 to 4) and 10 healthy subjects matched by age who performed the following: spirometry pre-and post-bronchodilator, a Glittre ADL test and two 6MWT on two consecutive days. RESULTS: The performance of COPD (FEV1%pred= 38.1±11.8, age=64±10 years, BMI=23.7±5.2 kg/ m²) was worse than the control group on TGlittre (5.26±2.9 min, 3.3±0.3 min, p<0.05) and 6MWT (434.97±105.18 m vs. 593.25±87.36 m, p<0.05). TGlittre correlated with the physical activity domain of the London Chest Activity of Daily Living (LCADL) scale (r=0.67, p<0.05) and with 6MWT when the total sample was analyzed (r=-0.64, p<0.05). The COPD group had a statistically higher (p<0.05) increase in dyspnea (Borg scale) than the control group for both TGlittre and 6MWT, with a similar heart rate and peripheral oxygen saturation variation in both groups (p&gt;0.05). CONCLUSIONS: The performance of COPD patients is worse than that of healthy subjects on the Glittre ADL test, with a greater increase in dyspnea and similar heart rates. 2011 artículo científico 1413-3555 https://www.redalyc.org/articulo.oa?id=235021132013 en http://www.redalyc.org/revista.oa?id=2350 Revista Brasileira de Fisioterapia application/pdf Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia Revista Brasileira de Fisioterapia (Brasil) Num.6 Vol.15
format Artículo científico
id redalyc_235021132013
institution Redalyc
language en
publishDate 2011
publisher Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia
spellingShingle Can the Glittre ADL test differentiate the functional capacity of COPD patients from that of healthy subjects?
Krislainy S. Corrêa
Salud
Evaluation
rehabilitation
pulmonary disease
chronic obstructive
activities of daily living
Can the Glittre ADL test differentiate the functional capacity of COPD patients from that of healthy subjects? Krislainy S. Corrêa Manuela Karloh Letícia Q. Martins Karoliny dos Santos Anamaria F. Mayer Salud Evaluation rehabilitation pulmonary disease chronic obstructive activities of daily living BACKGROUND: The Glittre ADL (TGlittre) test is a specifically designed to assess functional limitation in chronic obstructive pulmonary disease (COPD) patients. However, it is not known if it can differentiate the performance of these patients from healthy subjects. OBJECTIVES: To investigate whether the Glittre ADL test is able to differentiate the functional capacity of COPD patients from that of healthy subjects and to compare the cardiorespiratory response between Glittre ADL and the six-minute walk test (6MWT). METHODS: The study included 10 patients with COPD (GOLD 2 to 4) and 10 healthy subjects matched by age who performed the following: spirometry pre-and post-bronchodilator, a Glittre ADL test and two 6MWT on two consecutive days. RESULTS: The performance of COPD (FEV1%pred= 38.1±11.8, age=64±10 years, BMI=23.7±5.2 kg/ m²) was worse than the control group on TGlittre (5.26±2.9 min, 3.3±0.3 min, p<0.05) and 6MWT (434.97±105.18 m vs. 593.25±87.36 m, p<0.05). TGlittre correlated with the physical activity domain of the London Chest Activity of Daily Living (LCADL) scale (r=0.67, p<0.05) and with 6MWT when the total sample was analyzed (r=-0.64, p<0.05). The COPD group had a statistically higher (p<0.05) increase in dyspnea (Borg scale) than the control group for both TGlittre and 6MWT, with a similar heart rate and peripheral oxygen saturation variation in both groups (p&gt;0.05). CONCLUSIONS: The performance of COPD patients is worse than that of healthy subjects on the Glittre ADL test, with a greater increase in dyspnea and similar heart rates. 2011 artículo científico 1413-3555 https://www.redalyc.org/articulo.oa?id=235021132013 en http://www.redalyc.org/revista.oa?id=2350 Revista Brasileira de Fisioterapia application/pdf Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia Revista Brasileira de Fisioterapia (Brasil) Num.6 Vol.15
title Can the Glittre ADL test differentiate the functional capacity of COPD patients from that of healthy subjects?
topic Salud
Evaluation
rehabilitation
pulmonary disease
chronic obstructive
activities of daily living
url https://www.redalyc.org/articulo.oa?id=235021132013